StockNews.AI
DMAC
StockNews.AI
161 days

DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025

1. DMAC will announce full-year 2024 financial results on March 17th. 2. A conference call will discuss these results on March 18th.

Earnings
+5.48%Current Return
VS
-0.15%S&P 500
$5.4703/11 08:49 AM EDTEvent Start
$5.7703/12 03:32 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Upcoming financial results could indicate growth, potentially boosting investor confidence.

How important is it?

Financial disclosures may reveal progress or setbacks, influencing stock price significantly.

Why Short Term?

Immediate market reaction expected following financial results and conference call.

Related Companies

CRSPAVEORGEN
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that its full-year 2024 financial results will be released after the markets close on Monday, March 17th. DiaMedica will host a live conference call on Tuesday, March 18th at 7:00 AM Central Time to provide a business update and discuss financial results. Conference Call details: Date: Tuesday, M.

Related News